24
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Exploring Factors Affecting Acceptance of Fecal Microbiota Transplantation for Patients with Recurrent Urinary Tract Infections: a Descriptive Qualitative Study

ORCID Icon, , , , , , , , & ORCID Icon show all
Pages 1257-1269 | Received 29 Nov 2023, Accepted 23 Mar 2024, Published online: 17 Jun 2024

References

  • Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653–660. doi:10.1038/nrurol.2010.190
  • Kwok M, McGeorge S, Mayer-Coverdale J, et al. Guideline of guidelines: management of recurrent urinary tract infections in women. BJU Int. 2022;130 Suppl 3(Suppl 3):11–22. doi:10.1111/bju.15756
  • Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. 2018;18(1):107–117. doi:10.1080/14737167.2017.1359543
  • Lyonga EE, Toukam M, Nkenfou C, et al. Resistance pattern of Enterobacteriaceae isolates from urinary tract infections to selected quinolones in Yaoundé. Pan Afr Med J. 2015;21:105. doi:10.11604/pamj.2015.21.105.5469
  • Valentine-King M, Laytner L, Hines-Munson C, et al. Qualitative Analysis of a Twitter-Disseminated Survey Reveals New Patient Perspectives on the Impact of Urinary Tract Infection. Antibiotics (Basel). 2022;11(12). doi:10.3390/antibiotics11121687
  • Alanazi MQ. Evaluation of Health-Related Quality of Life in Women with Community-Acquired Urinary Tract Infections Using the EQ-5D-3L in Saudi Arabia. Patient Preference Adherence. 2020;14:2419–2426. doi:10.2147/ppa.S277367
  • Ioannou P, Plexousaki M, Dimogerontas K, et al. Characteristics of urinary tract infections in older patients in a tertiary hospital in Greece. Geriatr Gerontol Int. 2020;20(12):1228–1233. doi:10.1111/ggi.14080
  • Shaikh N, Craig JC, Rovers MM, et al. Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data. JAMA Pediatr. 2014;168(10):893–900. doi:10.1001/jamapediatrics.2014.637
  • Mathur P, Malpiedi P, Walia K, et al. Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: a multicentre, hospital-based, prospective surveillance study. Lancet Glob Health. 2022;10(9):e1317–e1325. doi:10.1016/s2214-109x(22)00274-1
  • Hsiao CY, Yang HY, Hsiao MC, Hung PH, Wang MC. Risk Factors for Development of Acute Kidney Injury in Patients with Urinary Tract Infection. PLoS One. 2015;10(7):e0133835. doi:10.1371/journal.pone.0133835
  • Li X, Fan H, Zi H, et al. Global and Regional Burden of Bacterial Antimicrobial Resistance in Urinary Tract Infections in 2019. J Clin Med. 2022;11(10):2817. doi:10.3390/jcm11102817
  • Gharbi M, Drysdale JH, Lishman H, et al. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. BMJ. 2019;364:l525. doi:10.1136/bmj.l525
  • Antushevich H. Fecal microbiota transplantation in disease therapy. Clin. Chim. Acta. 2020;503:90–98. doi:10.1016/j.cca.2019.12.010
  • Magruder M, Edusei E, Zhang L, et al. Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection. Gut Microbes. 2020;12(1):1805281. doi:10.1080/19490976.2020.1805281
  • Paalanne N, Husso A, Salo J, et al. Intestinal microbiome as a risk factor for urinary tract infections in children. Eur J Clin Microbiol Infect Dis. 2018;37(10):1881–1891. doi:10.1007/s10096-018-3322-7
  • Magruder M, Sholi AN, Gong C, et al. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019;10(1):5521. doi:10.1038/s41467-019-13467-w
  • Johnsen PH, Hilpüsch F, Cavanagh JP, et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol. 2018;3(1):17–24. doi:10.1016/s2468-1253(17)30338-2
  • Peyrin-Biroulet L, Pillot C, Oussalah A, et al. Urinary tract infections in hospitalized inflammatory bowel disease patients: a 10-year experience. Inflamm Bowel Dis. 2012;18(4):697–702. doi:10.1002/ibd.21777
  • Tariq R, Pardi DS, Tosh PK, Walker RC, Razonable RR, Khanna S. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency. Clin Infect Dis. 2017;65(10):1745–1747. doi:10.1093/cid/cix618
  • Biehl LM, Cruz Aguilar R, Farowski F, et al. Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection. Infection. 2018;46(6):871–874. doi:10.1007/s15010-018-1190-9
  • Jeney SES, Lane F, Oliver A, Whiteson K, Dutta S. Fecal Microbiota Transplantation for the Treatment of Refractory Recurrent Urinary Tract Infection. Obstet Gynecol. 2020;136(4):771–773. doi:10.1097/aog.0000000000004052
  • Aira A, Rubio E, Vergara Gómez A, et al. rUTI Resolution After FMT for Clostridioides difficile Infection: a Case Report. Infect Dis Ther. 2021;10(2):1065–1071. doi:10.1007/s40121-020-00365-8
  • Zhang Y, Xue X, Su S, et al. Patients and physicians’ attitudes change on fecal microbiota transplantation for inflammatory bowel disease over the past 3 years. Ann Transl Med. 2021;9(21):1619. doi:10.21037/atm-21-3683
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi:10.1093/intqhc/mzm042
  • Arnold JJ, Hehn LE, Klein DA. Common Questions About Recurrent Urinary Tract Infections in Women. Am Fam Physician. 2016;93(7):560–569.
  • Partington G. Qualitative Research Interviews: identifying Problems in Technique. Issues in Educational. 2001;11(2):32–44.
  • Kiger ME, Varpio L. Thematic analysis of qualitative data: AMEE Guide No. 131. Med Teach. 2020;42(8):846–854. doi:10.1080/0142159x.2020.1755030
  • Rowley J. Conducting research interviews. Management Research Review. 2012;35(3/4):260–271. doi:10.1108/01409171211210154
  • McNulty CA, Richards J, Livermore DM, et al. Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother. 2006;58(5):1000–1008. doi:10.1093/jac/dkl368
  • Bell JAH, Forcina V, Mitchell L, et al. Perceptions of and decision making about clinical trials in adolescent and young adults with Cancer: a qualitative analysis. BMC Cancer. 2018;18(1):629. doi:10.1186/s12885-018-4515-2
  • Parameswaran R, McNair A, Avery KN, et al. The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol. 2008;15(9):2372–2379. doi:10.1245/s10434-008-0042-8
  • Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - A systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer. 2008;44(11):1497–1506. doi:10.1016/j.ejca.2008.03.017
  • Ennis SS, Guo H, Raman L, Tambyah PA, Chen SL, Tiong HY. Premenopausal women with recurrent urinary tract infections have lower quality of life. Int J Urol. 2018;25(7):684–689. doi:10.1111/iju.13698
  • Bishop SJ, Gagne C. Anxiety, Depression, and Decision Making: a Computational Perspective. Annu Rev Neurosci. 2018;41:371–388. doi:10.1146/annurev-neuro-080317-062007
  • Paulus MP, Yu AJ. Emotion and decision-making: affect-driven belief systems in anxiety and depression. Trends Cognit Sci. 2012;16(9):476–483. doi:10.1016/j.tics.2012.07.009
  • Cartmell KB, Bonilha HS, Simpson KN, Ford ME, Bryant DC, Alberg AJ. Patient barriers to cancer clinical trial participation and navigator activities to assist. Adv Cancer Res. 2020;146:139–166. doi:10.1016/bs.acr.2020.01.008
  • Houghton C, Dowling M, Meskell P, et al. Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2020;10(10):Mr000045. doi:10.1002/14651858.MR000045.pub2
  • Jenkins V, Farewell V, Farewell D, et al. Drivers and barriers to patient participation in RCTs. Br J Cancer. 2013;108(7):1402–1407. doi:10.1038/bjc.2013.113
  • Keusch F, Rao R, Chang L, Lepkowski J, Reddy P, Choi SW. Participation in clinical research: perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(10):1604–1611. doi:10.1016/j.bbmt.2014.06.020
  • Madsen SM, Holm S, Riis P. Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a Grounded Theory approach. J Med Ethics. 2007;33(4):234–240. doi:10.1136/jme.2005.015255
  • Bleidorn J, Bucak S, Gágyor I, Hummers-Pradier E, Dierks ML. Why do - or don’t - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine. Ger Med Sci. 2015;13:Doc17. doi:10.3205/000221
  • Massett HA, Dilts DM, Bailey R, et al. Raising Public Awareness of Clinical Trials: development of Messages for a National Health Communication Campaign. J Health Commun. 2017;22(5):373–385. doi:10.1080/10810730.2017.1290715
  • de Lacey SL, Sanderman E, Smith CA. Acupuncture in reproductive medicine: the motivations of infertile women to participate in a randomised controlled trial. J Psychosom Obstet Gynaecol. 2018;39(2):112–120. doi:10.1080/0167482x.2017.1308349